HeartStart MRx Monitor/Defibrillator Model # M3535A - Product Usage: The HeartStart MRx is a lightweight, portable external defibrillator, offering two modes of operation for defibrillation: manual mode and semi-automatic mode (AED). In manual mode, the HeartStart MRx is a full featured manual defibrillator, designed for use by clinicians trained in Advanced Cardiac Life Support (ACLS). Manual operation allows users to select energy levels for external and internal defibrillation. Users may also perform synchronized cardioversion. Non-invasive external pacing is a device option. In AED mode, the HeartStart MRx allows the provider who is trained in Basic Life Support (BLS) to provide defibrillation therapy. The device analyzes a patient s rhythm and advises the user to deliver a shock. Voice prompts guide the user through the defibrillation process by providing instructions and patient information. The voice prompts are reinforced by messages that appear on the display. In both modes of operation, the HeartStart MRx utilizes impedance compensating biphasic truncated exponential therapy waveform. The HeartStart MRx can also be used for ECG monitoring of a patient using 3, 5 or 12 lead cables.
Publicado el 18 de septiembre de 2019 · Inicio del retiro: 16 de julio de 2019
Resumen
FDA registra el retiro Z-2488-2019 de dispositivos médicos de Clase II, publicado el 18 de septiembre de 2019 e iniciado el 16 de julio de 2019. Empresa responsable: Philips North America, LLC; Estado: Finalizado; Cantidad reportada: 2 units; Lote: Lot/ Serial # US00539461, US00539462. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
Non-conforming devices are identified, which may not have been included in prior field actions and may not have had a number of corrections applicable to these devices.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Philips North America, LLC
- Distribuidor
- US Nationwide distribution in the state of MA.
- Lote
- Lot/ Serial # US00539461, US00539462
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAThe IFU for the Autoclavable Temperature Probes: Part # 453564635891, providing in the packaging for the20 de abril de 2022
- FDAPhilips Sterilizable Defibrillator Paddles, Switched Internal Paddles, Model Numbers M4741A, M4742A, M4743A,4 de noviembre de 2020
- FDAPhilips SureSigns VM1SpO2, C02, Rec, model no. 863266 - Product Usage: The SureSigns VM1 is a patient monitor17 de junio de 2020
- FDAPhilips HeartStart XL Defibrillator/Monitor (Model number M4735A) - Product Usage: is for use in the hospital27 de mayo de 2020
- FDAROTEM ex-tem Rest of the world part No: 503-05 (ROW)18 de septiembre de 2019
- FDAMedtronic Micra MC1VR01, REF MC1VR01 (OUS only). Cardiac pacemaker.18 de septiembre de 2019
Preguntas sobre este retiro
¿HeartStart MRx Monitor/Defibrillator Model # M3535A - Product Usage: The HeartStart MRx is a lightweight, portable external defibrillator, offering two modes of operation for defibrillation: manual mode and semi-automatic mode (AED). In manual mode, the HeartStart MRx is a full featured manual defibrillator, designed for use by clinicians trained in Advanced Cardiac Life Support (ACLS). Manual operation allows users to select energy levels for external and internal defibrillation. Users may also perform synchronized cardioversion. Non-invasive external pacing is a device option. In AED mode, the HeartStart MRx allows the provider who is trained in Basic Life Support (BLS) to provide defibrillation therapy. The device analyzes a patient s rhythm and advises the user to deliver a shock. Voice prompts guide the user through the defibrillation process by providing instructions and patient information. The voice prompts are reinforced by messages that appear on the display. In both modes of operation, the HeartStart MRx utilizes impedance compensating biphasic truncated exponential therapy waveform. The HeartStart MRx can also be used for ECG monitoring of a patient using 3, 5 or 12 lead cables. fue retirado del mercado?
Sí. FDA publicó el retiro Z-2488-2019 el 18 de septiembre de 2019. Peligro reportado: Non-conforming devices are identified, which may not have been included in prior field actions and may not have had a number of corrections applicable to these devices.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter